Infinity Pharmaceuticals, Inc.
OTC: INFIQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Vishal Mehta
- Employees
- 30
- Headquarters
- Cambridge, United States
- IPO year
- 2000
- Market cap
- $9.1K
- Website
- https://www.ia.ooo
Loading INFIQ…
Loading profile data…Frequently asked questions about INFIQ
What does Infinity Pharmaceuticals, Inc. (INFIQ) do?
Infinity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel medicines for people with cancer. The company's product candidate, including eganelisib (IPI-549), an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Ph...
Where does INFIQ trade?
Infinity Pharmaceuticals, Inc. (INFIQ) trades on the Other OTC.
What sector is INFIQ in?
Infinity Pharmaceuticals, Inc. (INFIQ) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Infinity Pharmaceuticals, Inc.?
Vishal Mehta is the chief executive officer of Infinity Pharmaceuticals, Inc. (INFIQ).
Where is Infinity Pharmaceuticals, Inc. headquartered?
Infinity Pharmaceuticals, Inc. is headquartered in United States.
Does INFIQ pay a dividend?
Infinity Pharmaceuticals, Inc. (INFIQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did INFIQ go public?
Infinity Pharmaceuticals, Inc. (INFIQ) completed its initial public offering in 2000.